Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Basurto (28)

2023

  1. A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma

    Life, Vol. 13, Núm. 1

  2. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  3. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  4. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

    Life, Vol. 12, Núm. 12

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 165

  2. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma

    Critical Reviews in Oncology/Hematology, Vol. 159

2020

  1. BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

    PLoS ONE, Vol. 15, Núm. 3

2019

  1. Systematic review of the potential of MicroRNAs in diffuse large B cell lymphoma

    Cancers, Vol. 11, Núm. 2

2018

  1. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review

    Oncotarget, Vol. 9, Núm. 32, pp. 22850-22861

  2. Does arterial hypertension influence the onset of Huntington’s disease?

    PLoS ONE, Vol. 13, Núm. 5

  3. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

  2. Review of pharmacogenetics studies of L-asparaginase hypersensitivity in acute lymphoblastic leukemia points to variants in the GRIA1 gene

    Drug Metabolism and Personalized Therapy, Vol. 32, Núm. 1, pp. 1-9

2016

  1. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  2. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

    Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846

2015

  1. Exploring genetic factors involved in huntington disease age of onset: E2F2 as a new potential modifier gene

    PLoS ONE, Vol. 10, Núm. 7

  2. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

2014

  1. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8